Effects of gliclazide beyond metabolic controlCERIELLO, Antonio.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, S10-S15, SUP1Conference Paper

Gliclazide inhibits differentiation-associated biologic events in human monocyte-derived macrophagesMAMPUTU, Jean-Claude; LING LI; RENIER, Geneviève et al.Metabolism, clinical and experimental. 2006, Vol 55, Num 6, pp 778-785, issn 0026-0495, 8 p.Article

Development and validation of a new high-performance liquid chromatography method for the determination of gliclazide and repaglinide in pharmaceutical formulationsBERECKA, Anna; GUMIENICZEK, Anna; HOPKALA, Hanna et al.Journal of AOAC International. 2006, Vol 89, Num 2, pp 319-325, issn 1060-3271, 7 p.Article

Free radical scavenging activity of sulfonylureas: A clinical assessment of the effect of gliclazideJENNINGS, P. E; BELCH, J. J. F.Metabolism, clinical and experimental. 2000, Vol 49, Num 2, pp 23-26, issn 0026-0495, SUP1Conference Paper

Gliclazide^{(Ddiamicron° 30 mg)} : Nouvelle forme : L'évaluation n'en sort pas renforcée = Glizalide (Diamicron® 30 mg) : new formulationLa Revue Prescrire. 2002, Vol 22, Num 224, issn 0247-7750, p. 11Article

Kemutec mills for Servier in IrelandManufacturing chemist (London. 1981). 2001, Vol 72, Num 4, pp 39-40, issn 0262-4230Article

Suivi en médecine générale des diabétiques de type 2 récemment dépistés : Résultats après deux ans de traitement par gliclazide = Type II diabetes managmentLESOBRE, B; DE CHAMPVALLINS, M; BOUALLOUCHE, A et al.Concours médical (Paris). 1999, Vol 121, Num 34, pp 2674-2681, issn 0010-5309Article

The effect of gliclazide and glibenclamide on preconditioning of the human myocardiumLOUBANI, Mahmoud; FOWLER, Alan; STANDEN, Nicholas B et al.European journal of pharmacology. 2005, Vol 515, Num 1-3, pp 142-149, issn 0014-2999, 8 p.Article

Study of the solubilization of gliclazide by aqueous micellar solutionsALKHAMIS, Khouloud A; ALLABOUN, Hussien; AL-MOMANI, Wafa'A Y et al.Journal of pharmaceutical sciences. 2003, Vol 92, Num 4, pp 839-846, issn 0022-3549, 8 p.Article

Effect of gliclazide on islet transplantsJUANG, J.-H; KUO, C.-H; HSU, B. R.-S et al.Transplantation proceedings. 2002, Vol 34, Num 7, pp 2696-2697, issn 0041-1345, 2 p.Conference Paper

Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic ratsAL-SALAMI, Hani; BUTT, Grant; TUCKER, Ian et al.European journal of drug metabolism and pharmacokinetics. 2012, Vol 37, Num 2, pp 99-108, issn 0378-7966, 10 p.Article

The metabolism of CYP2C9 and CYP2C19 for gliclazide by homology modeling and docking studyYUAN YAO; HAN, Wei-Wei; ZHOU, Yi-Han et al.European journal of medicinal chemistry. 2009, Vol 44, Num 2, pp 854-861, issn 0223-5234, 8 p.Article

In Vitro and In Vivo Evaluation of a Novel Push-Pull Osmotic Pump with Orifices on Both Side SurfacesWEI LI; GANI DU; XINGGANG YANG et al.Drug development and industrial pharmacy. 2008, Vol 34, Num 12, pp 1350-1355, issn 0363-9045, 6 p.Article

Determination of glimepiride in human plasma by LC-MS-MSYÜZÜAK, N; ÖZDEN, T; EREN, S et al.Chromatographia (Wiesbaden). 2007, Vol 66, issn 0009-5893, S165-S168, SUPArticle

Effect of vitamin E and C supplementation combined with oral antidiabetic therapy on the endothelial dysfunction in the neonatally streptozotocin injected diabetic ratALPER, Gülinnaz; OLUKMAN, Murat; IRER, Seda et al.Diabetes/metabolism research and reviews (Print). 2006, Vol 22, Num 3, pp 190-197, issn 1520-7552, 8 p.Article

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetesCHARBONNEL, B; SCHERNTHANER, G; BRUNETTI, P et al.Diabetologia (Berlin). 2005, Vol 48, Num 6, pp 1093-1104, issn 0012-186X, 12 p.Article

Pioglitazone elicits long-term improvements in insulin sensitivity in patients with type 2 diabetes : comparisons with gliclazide-based regimensCHARBONNEL, B; RODEN, M; URQUHART, R et al.Diabetologia (Berlin). 2005, Vol 48, Num 3, pp 553-560, issn 0012-186X, 8 p.Article

Determination of aminoheterocycle and azabicycle in gliclazide bulk by capillary zone electrophoresis with amperometric detectionJIN LV; QINGJIANG WANG; XIANG CHEN et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 39, Num 3-4, pp 843-847, issn 0731-7085, 5 p.Article

Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetesBETTERIDGE, D. J; VERGES, B.Diabetologia (Berlin). 2005, Vol 48, Num 12, pp 2477-2481, issn 0012-186X, 5 p.Article

High-performance liquid chromatography with electrochemical detection for analysis of gliclazide in plasmaKUO, Chien-Yuan; WU, Shou-Mei.Journal of chromatography. 2005, Vol 1088, Num 1-2, pp 131-135, issn 0021-9673, 5 p.Conference Paper

Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazideMADDOCK, Helen L; SIEDLECKA, Sylvia M; YELLON, Derek M et al.Cardiovascular drugs and therapy. 2004, Vol 18, Num 2, pp 113-119, issn 0920-3206, 7 p.Article

Severe relapsing sulphonylurea-induced hypoglycaemia: a diagnostic and therapeutic challenge. AnswerLANGFORD, N. J; KRENTZ, A. J; MARTIN, U et al.Postgraduate medical journal. 2003, Vol 79, Num 928, issn 0032-5473, 120,123 [2 p.]Article

Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazidePARK, Ji-Young; KIM, Kyoung-Ah; PARK, Pil-Whan et al.Clinical pharmacology and therapeutics. 2003, Vol 74, Num 4, pp 334-340, issn 0009-9236, 7 p.Article

High frequency insulin pulsatility and type 2 diabetes: From physiology and pathophysiology to clinical pharmacologySCHMITZ, O; BROCK, B; HOLLINGDAL, M et al.Diabetes & metabolism. 2002, Vol 28, pp 4S14-4S20, issn 1262-3636, SUPConference Paper

Acute and short-term administration of a sulfonylurea (gliclazide) increases pulsatile insulin secretion in type 2 diabetesJUHL, Claus B; PØRKSEN, Niels; PINCUS, Steven M et al.Diabetes (New York, NY). 2001, Vol 50, Num 8, pp 1778-1784, issn 0012-1797Article